MetaVia is trading 5.8% up in pre-market at $1.47, with no clear catalyst identified. - The shares closed at $1.39 on October 22; no fresh company announcement explaining the October 23 move appeared in the sources reviewed. - The latest release on the company’s investor site was the October 13 appointment of its chief medical officer. Supplied market indicators were mixed, and no volume data was provided, leaving the move’s driver and trading activity unclear.